You are here:

Home
NICE Guidance
Conditions and diseases
Cancer
Bladder cancer

URO17 for detecting bladder cancer

Medtech innovation briefing
Reference number: MIB250
Published: 04 February 2021

Download (PDF)

Overview
Summary
The technology
Regulatory information
Equality considerations
Clinical and technical evidence
Expert comments
Expert commentators
Development of this briefing

Regulatory information

URO17 is CE-marked as an in-vitro diagnostic medical device.

Next page Equality considerations Previous page The technology